(VRTX) Vertex Pharmaceuticals - Performance 18.1% in 12m
Compare VRTX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
59.72%
#10 in Group
Rel. Strength
73.58%
#2019 in Universe
Total Return 12m
18.09%
#34 in Group
Total Return 5y
89.38%
#24 in Group
P/E -
(unknown) Percentile in Group
P/E Forward 30.1
75th Percentile in Group
PEG 1.45
87th Percentile in Group
FCF Yield -0.62%
74th Percentile in Group
12m Total Return: VRTX (18.1%) vs XBI (-11%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
ABBV NYSE AbbVie |
-2.97% | 17.7% | 234% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
UTHR NASDAQ United Therapeutics |
0.72% | 36.6% | 226% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
-3.97% | 23.4% | 39.7% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
AMGN NASDAQ Amgen |
-1.63% | 14.1% | 68.5% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
LONN SW Lonza |
-7.89% | 0.58% | 37% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
NBIX NASDAQ Neurocrine Biosciences |
-5.39% | -21.4% | 18.7% | 33.6 | 22.8 | 0.27 | 61.5% | 31.6% |
BIM PA Biomerieux |
1.3% | 15.8% | 12.1% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
KMDA NASDAQ Kamada |
1.65% | 24.1% | 14.1% | 27 | 25 | 1 | 58.7% | 15% |
Performance Comparison: VRTX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for VRTX
Total Return (including Dividends) | VRTX | XBI | S&P 500 |
---|---|---|---|
1 Month | 0.04% | -5.85% | -3.01% |
3 Months | 19.16% | -11.95% | -3.15% |
12 Months | 18.09% | -11.00% | 10.19% |
5 Years | 89.38% | 0.65% | 129.24% |
Trend Score (consistency of price movement) | VRTX | XBI | S&P 500 |
1 Month | -7.40% | -59.8% | -5.5% |
3 Months | 91.8% | -70.5% | -58.4% |
12 Months | 29.1% | -6.9% | 84.1% |
5 Years | 86.4% | -50% | 84.4% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #52 | 6.25% | 3.14% |
3 Month | #18 | 35.3% | 23.0% |
12 Month | #33 | 32.7% | 7.17% |
5 Years | #26 | 88.2% | -17.4% |
FAQs
Does VRTX Vertex Pharmaceuticals outperforms the market?
Yes,
over the last 12 months VRTX made 18.09%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.00%.
Over the last 3 months VRTX made 19.16%, while XBI made -11.95%.
Over the last 3 months VRTX made 19.16%, while XBI made -11.95%.
Performance Comparison VRTX vs Indeces and Sectors
VRTX vs. Indices VRTX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -2.64% | 3.05% | 4.75% | 7.90% |
US NASDAQ 100 | QQQ | -1.66% | 4.10% | 5.52% | 9.49% |
US Dow Jones Industrial 30 | DIA | -2.84% | 2.18% | 3.83% | 8.58% |
German DAX 40 | DAX | -1.34% | 3.42% | -12.0% | -3.60% |
Shanghai Shenzhen CSI 300 | CSI 300 | -2.35% | -0.19% | 20.0% | 8.97% |
Hongkong Hang Seng | HSI | -4.61% | -2.73% | 14.0% | 0.76% |
India NIFTY 50 | INDA | -3.67% | -7.83% | 15.1% | 17.4% |
Brasil Bovespa | EWZ | -2.75% | -8.25% | 12.8% | 29.8% |
VRTX vs. Sectors VRTX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -1.10% | 3.85% | -3.36% | -1.12% |
Consumer Discretionary | XLY | -3.40% | 3.87% | 1.39% | 4.03% |
Consumer Staples | XLP | -5.43% | 1.88% | 3.91% | 7.06% |
Energy | XLE | -3.73% | -7.98% | -0.83% | 17.3% |
Financial | XLF | -3.12% | 2.74% | -7.41% | -4.16% |
Health Care | XLV | -3.06% | 3.20% | 9.45% | 16.4% |
Industrial | XLI | -2.95% | 0.73% | 5.46% | 9.56% |
Materials | XLB | -3.74% | -0.47% | 12.9% | 22.0% |
Real Estate | XLRE | -4.68% | 2.73% | 7.87% | 4.73% |
Technology | XLK | -1.51% | 4.05% | 9.87% | 16.1% |
Utilities | XLU | -5.93% | -0.78% | 5.63% | -7.14% |
Aerospace & Defense | XAR | -2.04% | -1.24% | 0.83% | -2.84% |
Biotech | XBI | 1.92% | 5.89% | 22.5% | 29.1% |
Homebuilder | XHB | -3.14% | -0.11% | 24.1% | 25.8% |
Retail | XRT | -4.94% | 0.54% | 8.83% | 22.9% |